Opioid bill heads to President Trump...

Senate Clears Opioid Bill With Partial IMD Repeal, FDA Labeling Authorities

October 04, 2018
The Senate cleared a massive bicameral package of opioid legislation on Wednesday (Oct. 3) by a vote of 98-1, with Sen. Mike Lee (R-UT) as the sole "no" vote, and Sen. Ted Cruz (R-TX) not voting. The package aims to stem the opioid crisis through myriad bipartisan provisions that affect FDA and CMS, among other federal agencies. The package includes measures to partially repeal a prohibition on Medicaid paying for treatment at certain inpatient facilities, expand access to addiction treatment,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.